Skip to main content
. 2018 Aug 10;35:167–177. doi: 10.1016/j.ebiom.2018.08.011
AdPC prostate adenocarcinoma
NEPC neuroendocrine prostate cancer
SRRM4 serine/arginine repetitive matrix 4 (also known as nSR100)
SOX2 sex determining region Y-box 2
CRPC castration-resistant prostate cancer
AR androgen receptor
CRPC-Ad castration-resistant prostate adenocarcinoma
t-NEPC treatment-induced neuroendocrine prostate cancer
TP53 tumor protein p53
RB1 retinoblastoma transcriptional corepressor 1
PTEN phosphatase and tensin homolog
NE neuroendocrine
SC stem cell
REST RE1 silencing transcription factor
EZH2 enhancer of zeste 2 polycomb repressive complex 2
LnNE SRRM4-transduced LNCaP cell-derived neuroendocrine prostate cancer model
PSA prostate-specific antigen
VPC Vancouver Prostate Centre
RISH RNA in situ hybridization
IHC immunohistochemistry
E-Cad E-cadherin
SYP synaptophysin
BrdU bromodeoxyuridine
Doce docetaxel
CPT camptothecin
GSEA gene set enrichment analysis
PDX patient-derived xenograft
GEMM genetically engineered mouse model
GEO gene expression omnibus
WT wild-type
SKO single knock-out
DKO double knock-out
TKO triple knock-out
LE luminal epithelial
c-PARP cleaved poly(ADP-ribose) polymerase
GO gene ontology
DuNE SRRM4-transduced DU145 cell-derived neuroendocrine prostate cancer model